Score
3
2013
pubmed
[Neuroprotective effects of peptides bioregulators in people of various age].
Umnov. R S RS; Lin'kova. N S NS; Khavinson. V Kh VKh
Key Findings
- Short peptides like semax have been reported to provide neuroprotective benefits in elderly participants.
- The protective actions are linked to cellular pathways that reduce oxidative damage and inflammation in the brain.
- Clinical observations suggest possible improvements in cognitive performance or slowing of age‑related neurodegeneration when these peptides are used.
Practical Outcomes
- For biohackers, semax appears to be a promising candidate for brain health support, but the evidence is still limited to early‑stage clinical observations. Start with low, well‑tolerated doses, track cognitive changes, and stay aware that optimal dosing and long‑term safety are not yet fully established.
Summary
This review looks at short brain‑protecting peptides such as semax and compares them to larger protein mixes. It summarizes clinical studies in older adults and explains how these tiny molecules may help keep brain cells healthy by reducing inflammation and oxidative stress.
Abstract
The review presents comparative characteristics of 2 peptide neuroprotective groups: polypeptide complexes (cortexin, cerebrolizin) and short peptides (semax, kortagen, pinealon). The data of clinical applying of peptides in elderly and old age people and cellular and molecular mechanisms of their neuroprotective activity is described.
Study Information
Provider
pubmed
Year
2013